For richer charts and full features, open SpikePanel on desktop.
Graded daily on value C-, growth A-, profitability C, momentum D-, revisions D-. Sector-relative, identical for every user.
Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $BNTX are available with SpikePanel Pro.
Key events, in time order
gotistobart在鳞状非小细胞肺癌III期非关键阶段更新数据显示,中位总生存期18.5个月对比多西他赛10个月,风险比0.56,死亡风险降低44%。
Phase 3 met, but PFS gain modest; ILD more frequent incl. severe/fatal cases
CEO and 10% owner sells under trading plan, ~$5.9M total, draws attention
CEO sold 79K shares on Sep 21-22, extending selling trend
Phase 3 trial shows clinically meaningful OS benefit in pretreated squamous NSCLC
Trial termination in oncology pipeline weighs, shares fall Friday
Q2 2026 revenues were EUR 106 million, down from EUR 261 million in the prior year quarter, mainly due to lower COVID-19 vaccine demand in the U.S.
None yet
None yet
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice